DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/kswpbr/global_pulmonary) has announced the addition of the "Global Pulmonary Hypertension Drug Pipeline Capsule - 2012 Update" report to their offering.
Fore Pharma's latest report 'Global Pulmonary Hypertension Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Pulmonary Hypertension market. It covers active Pulmonary Hypertension pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.
This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.
Topics Covered:
1. Pulmonary Hypertension - Disease Overview
2. Pulmonary Hypertension Pipeline Overview
3. Pulmonary Hypertension Phase 3 Clinical Trial Pipeline Insights
4. Pulmonary Hypertension Phase 2 Clinical Trial Pipeline Insights
5. Pulmonary Hypertension Phase 1 Clinical Trial Pipeline Insights
6. Pulmonary Hypertension Preclinical Research Pipeline Insights
7. Pulmonary Hypertension Discovery Stage Pipeline Insights
8. Pulmonary Hypertension Drug Development Activities - Geographic Landscape
8.1. Pulmonary Hypertension R&D Activities in North America
8.2. Pulmonary Hypertension R&D Activities in Europe
9. Pulmonary Hypertension Pipeline - Licensing Activities
Table 1. Pulmonary Hypertension Pipeline Molecules - Phase 3 Clinical Trial
Table 2. Pulmonary Hypertension Pipeline Molecules - Phase 2 Clinical Trial
Table 3. Pulmonary Hypertension Pipeline Molecules - Phase 1 Clinical Trial
Table 4. Pulmonary Hypertension Pipeline Molecules - Preclinical Research
Table 5. Pulmonary Hypertension Pipeline Molecules - Drug Discovery
Table 6. Pulmonary Hypertension R&D Activities by Geography
Table 7. Pulmonary Hypertension Pipeline Molecules - North America
Table 8. Pulmonary Hypertension Pipeline Molecules - Europe
Table 9. Pulmonary Hypertension Pipeline - Licensing Activities
Figure 1. Pulmonary Hypertension Pipeline Molecules by R&D Stage
Figure 2. Pulmonary Hypertension R&D Activities by Geography
For more information visit http://www.researchandmarkets.com/research/kswpbr/global_pulmonary